Joe Wolk

JNJ

Pharma

J&J logs strong innovative drug sales despite Stelara's decline

For the first time, J&J’s global innovative medicines sales have reached more than $15 billion in a single quarter.

Fraiser Kansteiner Jul 16, 2025 11:19am

JNJ

J&J lifts 2025 sales guidance despite looming tariff threat

Apr 15, 2025 11:55am

J&J's Kenvue spinoff provides $13.2B in potential M&A firepower

Aug 30, 2023 10:45am

jnj

J&J takes major hit from litigation cost in 2023's first quarter

Apr 18, 2023 11:15am

layoff staff workforce

J&J is letting go of 64 staffers in Manhattan

Oct 20, 2022 10:59am

J&J reduces revenue forecast for 2022, dropping vaccine sales

Apr 19, 2022 11:08am